Evolution of Pulsed Oxygen Saturation During Interval Training Compared to Continuous Training in COPD Patients
Study Details
Study Description
Brief Summary
A problem often observed during exercise training is oxygen desaturation exclusively during exercise in some patients. In the case of exercise-induced desaturation, it may be suggested to train these patients in interval training to limit exercise-induced desaturation. Interval training consists of alternating active phases of short duration (often 30 seconds to 1 minute) followed by a short active or passive recovery phase of equivalent duration to the previous phase. Investigators therefore hypothesise that interval training on a cycloergometer or treadmill can limit exercise-induced desaturation in COPD patients.
The aim of the study is to observe the evolution of pulsed oxygen saturation between a continuous training session and a interval training session.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Continuous training session
|
Other: Continuous training session
Continuous training consists of a 5 minute warm up, 5 minute cool down and 20 minutes of moderate intensity work. The workload is set at 60% of the patient's maximum power
|
Interval Training session
|
Other: Interval training session
Interval training consists of a 5-minute warm-up, a 5-minute cool-down and 20 minutes of alternating 60 seconds of high-intensity work (100% of the maximum power recorded in the incremental test that was carried out when the patient was admitted to the pulmonary rehabilitation department) and 60 seconds of unloaded pedalling or rest.
|
Outcome Measures
Primary Outcome Measures
- Difference in oxygen pulsed saturation [One week]
Difference in minimum saturation during both exercise, the measurement will be performed with a pulse oximeter (Spirodoc, MIR)
Secondary Outcome Measures
- Difference in oxygen pulsed saturation [One week]
Difference in mean pulsed oxygen saturation and the time spent with a pulsed oxygen saturation below 90% during the two training sessions. The measurement will be performed with a pulse oximeter (Spirodoc, MIR)
- Difference in peripheral muscle oxygenation [One week]
Muscle oxygenation (arbitrary unit) will be evaluated using Near-infrared spectroscopy technology. the measurement will be performed with a Near Infrared spectroscopy (Portamon, Artinis Medical Systems)
- Difference in respiratory rate [One week]
Difference in respiratory rate will be measured breath-by-breath using a portable spirometer (Spirodoc, MIR)
- Difference in tidal volume [One week]
Difference in tidal volume will be measured breath-by-breath using a portable spirometer (Spirodoc, MIR)
- Difference in inspiratory capacity [One week]
Difference in inspiratory capacity will be measured using a portable spirometer (Spirodoc, MIR)
- Difference in Dyspnea [One week]
Dyspnea peak during exercise using the modified Borg scale 0-10, 0 no dyspnea, 10 maximal dyspnea
- Difference in muscle discomfort [One week]
Muscle discomfort peak during exercise using the modified Borg scale 0-10, 0 no dyspnea, 10 maximal dyspnea
Eligibility Criteria
Criteria
Inclusion Criteria:
-
a diagnosis of COPD
-
participating in a pulmonary rehabilitation programme
-
with an exercise-induced desaturation less than 90%
-
no oxygen supplementation
Exclusion Criteria:
-
Under 18 years of age
-
Pregnant woman
-
Person not affiliated to a health insurance regime or not benefiting from a social security regime
-
Patient under curatorship, guardianship or safeguard of justice
-
Patient speaking a language other than French
-
Patient with severe hypoxaemia (SpO2 ≤ 80%) during exercise
-
Patient having had a moderate or severe exacerbation (hospitalisation for respiratory reasons) in the previous 4 weeks
-
Patients with orthopaedic, rheumatic, vascular or neurological pathology limiting their ability to make an effort
-
Breastfeeding women
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Groupe Hospitalier du Havre | Le Havre | Normandie | France | 76290 |
Sponsors and Collaborators
- Groupe Hospitalier du Havre
- Medrinal Clement
- Combret Yann
- Machefert Margaux
Investigators
- Principal Investigator: Guillaume Prieur, PT, PhD, Groupe Hospitalier du Havre
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2022-A02087-36